In a subsequent study, Hedenfalk et al (2003) proposed novel classes for the familial non-BRCA1/BRCA2 breast tumours and a different expression profile to those of the BRCA1- and BRCA2-associated tumours reported earlier (Hedenfalk et al, 2003). This evidence concerns the gene BRCA2 and breast neoplasm.